Sonnet BioTherapeutics Inc. (SONN) Statistics & Valuation Metrics - Stocknear

Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
2.85
-0.05 (-1.72%)
At close: Sep 05, 2025, 3:59 PM
2.96
3.86%
After-hours: Sep 05, 2025, 07:58 PM EDT

Sonnet BioTherapeutics Statistics

Share Statistics

Sonnet BioTherapeutics has 6.69M shares outstanding. The number of shares has increased by 386.81% in one year.

6.69M
386.81%
3.27%
0.05%
6.16M
7,087
0.17%

Short Selling Information

The latest short interest is 1.88M, so 27.77% of the outstanding shares have been sold short.

1.88M
27.77%
27.88%
1.92

Valuation Ratios

The PE ratio is -0.59 and the forward PE ratio is -0.03. Sonnet BioTherapeutics's PEG ratio is 0.01.

-0.59
-0.03
235.35
3174.7
-9.02
-0.51
0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Sonnet BioTherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of -0.27.

0.66
0.66
-0.27
-0.01
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1.43K
$-572.09K
13
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -59.11% in the last 52 weeks. The beta is 1.22, so Sonnet BioTherapeutics's price volatility has been higher than the market average.

1.22
-59.11%
3.93
2.14
39.92
4,062,287

Income Statement

In the last 12 months, Sonnet BioTherapeutics had revenue of 18.63K and earned -7.44M in profits. Earnings per share was -11.35.

18.63K
18.63K
-11.85M
-7.44M
-11.77M
-11.85M
-11.35
Full Income Statement

Balance Sheet

The company has 149.46K in cash and 130.86K in debt, giving a net cash position of 18.59K.

149.46K
130.86K
18.59K
-117.68M
2.06M
-3.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.61M and capital expenditures 3, giving a free cash flow of -8.61M.

-8.61M
3
-8.61M
-13.14
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -63617.91% and -39929.3%.

100%
-63617.91%
-39929.3%
-39929.3%
-63171.67%
-63617.91%
-46213.48%

Dividends & Yields

SONN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SONN is $20, which is 601.8% higher than the current price. The consensus rating is "Buy".

$20
601.8%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Sep 30, 2024. It was a backward split with a ratio of 1:8.

Sep 30, 2024
backward
1:8

Scores

-109.1
2